24/7 Patient Assistance: 760-405-8205

Nathan Pennell, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Laryngeal Cancer Lung Cancer Ovarian Cancer Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Nathan Pennell started his medical career at the University of Florida College of Medicine in Gainesville and completed his residency in medical oncology at the Brigham & Women’s Hospital, one of the leading mesothelioma research centers in the United States. Dr. Pennell finished a fellowship at the Dana-Farber Cancer Institute Harvard Medical School in 2007. Dr. Pennell currently practices at the Cleveland Clinic’s Taussig Cancer Institute as the Director of the lung cancer medical oncology program and specializes in clinical trials for mesothelioma and other lung cancers. Numerous research grants and awards recommend Dr. Pennell as one of the country’s leading young mesothelioma doctors.

  • Education & Training


    University Of Florida Graduated in 2002

    Medical School


    Brigham and Womens Hospital Completed in 2003

    Internship Hospital


    Brigham and Womens Hospital Completed in 2005

    Residency Hospital


    Dana-Farber Cancer Institute Completed in 2007

    Fellowship Hospital

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Cleveland Clinic

    Languages: English/Spanish


    2049 E 100th St

    Cleveland, Ohio 44195

    Read More
  • Publications & Memberships

    Dr. Nathan Pennell has contributed to 3 publications.

    Fast-Growing Plasmacytoma.

    Abbas, H.,Karimianpour, A.,Pennell, N. A.; Am. J. Med. Sci

    See more >>

    Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer.

    Halmos, B.,Pennell, N. A.,Fu, P.,Saad, S.,Gadgeel, S.,Otterson, G. A.,Mekhail, T.,Snell, M.,Kuebler, J. P.,Sharma, N.,Dowlati, A.; Oncol

    See more >>

    EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data.

    Clifford BT Fu P Pennell NA Halmos B Leidner RS; Transl Lung Cancer Res

    See more >>


    American Society of Clinical Oncology